• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Comprehensive Care Centers for PH

February 4, 2015 By Dr. Jeremy Feldman

A new era in pulmonary hypertension care has begun. The Pulmonary Hypertension Association has accredited 11 programs across the country that offer the highest level of patient care. These centers have physicians with deep expertise and commitment, nurse coordinators that ensure that patients receive the highest level of attention. and an active research program. The designation of Comprehensive Care Center (CCC) also requires the programs to be expert in all treatment options, have well trained nurses that deliver care for hospitalized patients and an institutional commitment to patients with pulmonary hypertension.

What Does It Mean To Be An Accredited CCC?

PH TEAMAs the director of an accredited CCC I can share with you what it means from the inside out. First, the two physicians that deliver care are ultra-specialized in pulmonary hypertension. We both spent extra time in our training to master the physiology, diagnostics and treatment of the disease. Next, we have two full time nurses that understand what patients with PAH need and are expert in navigating the healthcare system with our patients. We have a medical assistant and an administrative assistant that are all integral to patient care. Next, we have 5 research coordinators that allow us to offer an array of clinical research studies to our patients. We have clear protocols for the delivery of patient care in the hospital and in the outpatient setting. The nurses that deliver bedside care for hospitalized patients are carefully trained and required to pass competency tests that ensure that they are knowledgeable about PAH. We have comprehensive protocols and procedures detailing how medications are used to treat PAH. Our pharmacists are trained in PAH medications and the inpatient pharmacy stocks all the medications that we need to treat any patient with PAH.

Our team includes other specialists with whom we have worked for years that allow us to collaboratively care for any patient. We also have close relationships with several lung transplant centers including a lung transplant program in our home-base hospital. We have chaplains, nutritionists, social workers and physical therapists that are very familiar with caring for PAH patients. We also have a PH support group that meets regularly.

Lastly, I think it is important that patients and their families understand that centers that have taken the time and energy to become Comprehensive Care Centers have also invested a large amount of money in the process of accreditation. The cost to the center is approximately $15,000 for the first 3 years and then perhaps $10,000 each three year period to maintain accreditation.

Currently Accredited Comprehensive Care Centers.

Arizona

Arizona Pulmonary Specialists, LTD

3330 North 2nd Street, #300

Phoenix, AZ 85012

Director: Jeremy Feldman, MD

Appointments: (602) 443-0184

California

Cottage Health System

Cottage Pulmonary Hypertension Center

2403 Castillo Street, Suite 206

Santa Barbara, CA 93105

Director: Jeffrey S. Sager, MD

Appointments: (805) 898-8840

Stanford University

Vera Moulton Wall Center for Pulmonary Vascular Disease

300 Pasteur Drive, Rm H3143

Stanford, CA 94305

Director: Roham T. Zamanian, MD

Appointments: (650) 723-6983

Colorado

University of Colorado Denver | Anschutz Medical Campus 

Pulmonary Hypertension Program

12605 E. 16th Ave, Room 3.2203

Aurora, CO 80045

Director: David Badesch, MD & Todd Bull, MD

Appointments: (720) 848-6518

Kentucky

Kentuckiana Pulmonary Associates 

100 West Market Street
 Suite 2

Louisville, KY 40202

Director: John Wesley McConnell, MD

Appointments: (502) 587-8000

Michigan

University of Michigan 

1500 East Medical Center Drive

Ann Arbor, MI 48109-5853

Director: Vallerie V. McLaughlin, MD

Appointments: (888) 287-1082

Minnesota

Mayo Clinic

200 1st Street SW

Rochester, MN 55905

Director: Robert P. Frantz, MD

Appointments: (502) 587-8000

Missouri

Washington University at Barnes-Jewish Hospital

4921 Parkview Place
 Suite B

St. Louis, MO 63110

Director: Murali M. Chakinala, MD

Appointments: (314) 454-8917

New York

Columbia University-New York Presbyterian Hospital

3959 Broadway 
CH-2N, Division of Pediatric Cardiology

New York, NY 10032

Director: Erika Berman Rosenzweig, MD

Appointments: (212) 305-4436

Weill Cornell Medical Center-New York Presbyterian Hospital

520 East 70th Street

New York, NY 10021

Director: Evelyn Horn, MD

Appointments: (212) 746-2381

Ohio

University of Cincinnati

University of Cincinnati Medical Center Pulmonary Hypertension Program
UC Health Physicians Office (Clifton)

222 Piedmont Avenue Suite 4300

Cincinnati, OH 45219

Director: Jean Elwing, MD

Appointments: (513) 475-8523

Pennsylvania

University of Pennsylvania

Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania


3400 Civic Center Boulevard

Philadelphia, PA 19104

Penn Presbyterian Medical Center


51 North 39th Street

Philadelphia, PA 19104

Director: Steven M. Kawut, MD, MS

Appointments: 800-789-PENN (7366)

Rhode Island

Rhode Island Hospital – Brown University

Rhode Island Hospital Pulmonary Hypertension Center


593 Eddy Street

Providence, RI 02903

Director: James Klinger, MD

Appointments: (401) 444-3570

Texas

University of Texas Southwestern Medical School

UT Southwestern Pulmonary Hypertension Program


5939 Harry Hines Blvd, Ste 600

Dallas, TX 75390

Director: Kelly M. Chin, MD, MSCS

Appointments: (214) 645-5505

Virginia

Inova Fairfax Hospital

Inova Advanced Lung Disease Management Program

3300 Gallows Road

Falls Church, VA 20042

Directors: Steven D. Nathan, MD & Oksana A. Shlobin, MD

Appointments (New Patients): (703) 776-6168

Appointments (Established Patients): (703) 776-2986

Virginia Commonwealth University

411 East Marshall Street

Richmond, VA 23298

Director: Dan Grinnan, MD

Appointments: (804) 828-2161

Filed Under: PH Doctors & Centers

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Internal anatomy of the pulmonary arteries

Minimally Elevated Pulmonary Pressures

By Dr. Jeremy Feldman

What Do They Mean? Mild PAH? We receive many emails from our readers inquiring whether having borderline to minimally

Altitude and PAH

How High Is Too High- Altitude And PAH

By Dr. Jeremy Feldman

Has your doctor advised that you avoid high elevation?  This is a common problem.  The higher the elevation (or

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives